The process of drawing blood from veins is known as phlebotomy. The procedure, also known as venipuncture, is primarily performed by specialists called phlebotomists. Medical laboratory scientists, doctors, and nurses often perform phlebotomy process as well. Phlebotomy is carried out for a range of reasons such as blood donations, medical testing, and research. Light blue top tubes are used for performing coagulation tests. Blood clotting or coagulation is the method by which blood changes its form. It forms a lump known as clot. This process leads to hemostasis, and prevent the blood loss from the body. The course of action of coagulation includes activation, bonding, and accumulation of platelets in addition to deposition and development of fibrin. Disorder related to clotting can result in thrombosis or hemorrhage. Phlebotomy tubes with light blue stoppers primarily contain two additives: sodium citrate (3.2% or 3.8%) and Citrate, theophylline, adenosine, dipyridamole) or CTAD. The citrate acts as an anticoagulant. It binds the calcium present in the blood that is required for clotting. As the additive gives a whole blood sample that is plasma and red blood cells, the light blue phlebotomy tubes have buffered tri-sodium citrate solution as well.
Get PDF Brochure Of This Research Report @
https://www.coherentmarketinsights.com/insight/request-pdf/143
Various tests are performed using the light blue phlebotomy tube. Some of them are Partial Thromboplastin Time (PTT), Fibrin degradation products (FDP), Thrombin Time (TT), Prothrombin Time (PT), Fibrinogen, and D-dimer. The global light blue tube phlebotomy market is expected to swell at a considerable rate in the near future. Rise in health awareness has resulted in the increase in blood diagnostic tests; particularly coagulation tests owing to mounting incidences of low platelet count, increased prevalence of liver diseases, as well as growth in number of surgeries are factors that will be responsible for the growth of light blue tube phlebotomy market.
Light Blue Tube Phlebotomy Market Taxonomy
On the basis of type of end user the global light blue tube phlebotomy market is classified into:
Hospitals
Diagnostic Centers
Medical Clinics
Others
An important factor for using light blue top tubes is the amount of blood extracted in the tubes. The tubes should be filled to the brim for obtaining accurate results. The blood should continue to flow from the patient’s body into the tube until the tube is full and the blood flow ceases. If the blood is extracted through a syringe, the optimum level (as marked in most of the light blue top tubes) should be maintained. This factor is important because light blue top tubes are used for coagulation tests which require 9:1 blood to anticoagulant ratio.
Asia Pacific to be growth engine for global light blue tube phlebotomy market
Increasing incidence of blood related diseases is projected to create a highly conducive environment for growth of the global light blue tube phlebotomy market. According to Center for Disease Control and Prevention, almost 1 to 2 people could be affected by DVT/PE. Pulmonary embolism (PE) typically occurs when a blood clot known as a deep vein thrombosis (DVT), habitually in the leg, moves to the lungs and form a lump, thereby blocking a blood vessel. It results into to low oxygen levels in the blood. It can harm the lung and may cause heart failure as well. Therefore, a blood coagulation test is usually suggested to patients with a history of such diseases. In South Asia, particularly in India, the blood fibrinogen level is usually high, owing to high prevalence of CHD or coronary heart diseases and elevated levels of glycoprotein IIb/IIIa which work as a receiver for fibrinogen. Moreover, according to a report by Journal of Thrombosis and Hemostatis, there is a growing emphasis upon the requirement of a controlled and randomized evaluation with clinical result measurement to ascertain that thromboprophylaxis (avoidance of thromboembolic disease or impediment of blood vessels by blood clot) is crucial in joint surgery in Asia. As blood coagulation tests are generally recommended before and after a surgery, escalation in the number of surgeries around the world is expected fuel the light blue tube phlebotomy market during the forecast period.
Request Sample Copy of Research Report @
https://www.coherentmarketinsights.com/insight/request-sample/143
Key players in the global light blue tube phlebotomy market
Some of the major competitors operating in the global light blue tube phlebotomy market are Greiner BioOne, Medical Expo, CML Biotech Pvt. Ltd., Ajosha BioTeklik Pvt. Ltd., New MicroMed International Pvt. Ltd., FL Medical, Gosselin, and Advacare Pharma.
Key Developments
Key players in the market are focused on various growth strategies such as product launches, in order to expand their product portfolio and gain competitive edge in the market. For instance, in May 2019, Greiner Bio-One launched MiniCollect K2EDTA Capillary Collection Tube. These capillary are intended for the collection of collection, transport, and evaluation of capillary samples.
Key players in the market are involved in various growth strategies such as product launches, in order to expand their product portfolio and gain competitive edge in the market. For instance, in October 2018, Greiner Bio-One launched VACUETTE Blood Collection Tubes, which is made from virtually unbreakable PET plastic.
About Coherent Market Insights
Coherent Market Insights is a prominent market research and consulting firm offering action-ready syndicated research reports, custom market analysis, consulting services, and competitive analysis through various recommendations related to emerging market trends, technologies, and potential absolute dollar opportunity.
Contact Us
Mr. Shah
Coherent Market Insights
1001 4th Ave, #3200
Seattle, WA 98154
Tel: +1-206-701-6702
Email: [email protected]
The process of drawing blood from veins is known as phlebotomy.
Blood clotting or coagulation is the method by which blood changes its form.
This process leads to hemostasis, and prevent the blood loss from the body.
Some of them are Partial Thromboplastin Time (PTT), Fibrin degradation products (FDP), Thrombin Time (TT), Prothrombin Time (PT), Fibrinogen, and D-dimer.
The global light blue tube phlebotomy market is expected to swell at a considerable rate in the near future.
The tubes should be filled to the brim for obtaining accurate results.
Factors such as increasing incidence of cardiovascular diseases and obesity, physician preference of laboratory testing rather self-testing, growing awareness and adoption of preventive healthcare, government initiatives to improve the quality of testing, and rapid growth in the geriatric population are propelling the growth of this market.
Moreover, emerging economies offer significant growth opportunities for players operating in the cholesterol testing services market.
On the other hand, rapidly growing home/self-testing and emergence of noninvasive cholesterol testing methods are the major factors that may limit growth of the market to a certain extent.The global Cholesterol Screening/ Cholesterol Lab Testing Services Market is expected to reach USD 17.57 Billion by 2021 from an estimated value of USD 11.96 Billion in 2016, growing at a CAGR of 8% during the forecast period.Ask for PDF Brochure: - https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=180941049The cholesterol testing services market is segmented on the basis of type of customer and region.
Based on type of customer, the market is segmented into physicians/providers and hospitals; employers, health plans, and Managed Care Organizations (MCOs); government agencies, Accountable Care Organizations (ACOs), and Integrated Delivery Networks (IDNs); and patients.
The patient-driven cholesterol testing segment is expected to grow at the highest CAGR during the forecast period, mainly due to increasing awareness and adoption of preventive healthcare, availability of lab test services for patients without any physician intervention thus reducing the waiting time to get appointment from physicians, and online access to reports and readings through smartphones.Based on region, the cholesterol testing services market is segmented into North America, Europe, Asia, and the Rest of the World (RoW).
In 2016, North America is expected to dominate the market, followed by Europe.
The global patient temperature management market size was worth USD 2.3 billion in 2016 which is anticipated to grow at a CAGR of more than 7.9% during the forecast period.
The key factor contributing to the market growth of patient temperature management is the rise in number of surgeries performed.
To prevent this, warming devices are used to eliminate intraoperative hypothermia.The rising prevalence of heart diseases such as cardiac arrest has increased the demand for patient temperature management in order to prevent adverse effects of high temperature on the brain and prevent further complications.Based on products, the market is categorized into patient cooling and warming systems.
Request Sample Copy of This Market Research @ https://www.millioninsights.com/industry-reports/patient-temperature-management-market/request-sample Patient cooling systems is expected to witness an attractive growth over the forecast period.
This is due to the rise in number of cardiac surgeries being performed that requires cooling systems to eliminate the adverse effect of high temperature causing brain trauma injuries and neurologic outcomes.Increasing incidence of cancer and chronic cardiovascular diseases has resulted in the boost of the market.
In order to prevent this, adjuncts such as patient warming systems are used along with chemotherapy and radiation therapy.Increasing prevalence of chronic cardiovascular diseases, especially cardiac arrest has led to an increase in demand for cooling systems in order to prevent adverse effects of high temperature on the brain.
The global contact lenses market size is projected to reach USD 12.05 billion by 2026, exhibiting a CAGR of 4.8% during the forecast period.
However, the market was worth USD 8.35 billion in 2018.
This information is published in a recent report by Fortune Business Insights, titled, “Contact Lenses Market Size, Share & Industry Analysis, By Modality (Reusable and Disposable), By Design (Toric, Multi-Focal, and Spherical), By Distribution Channel (Retail Stores, Online Stores, and Ophthalmologists), and Regional Forecast, 2019-2026.” As per the report, rising per capita healthcare expenditure and increasing incidence of astigmatism and myopia are expected to affect the market positively.For more information in the analysis of this report, visit: https://www.fortunebusinessinsights.com/industry-reports/contact-lenses-market-101775Fortune Business Insights lists out some of the renowned companies operating in the contact lenses market.
They are as follows:ContamacCooperVisionHOYA CorporationEssilorBausch & Lomb IncorporatedJohnson & Johnson Vision Care, Inc. (Johnson & Johnson Services, Inc.)ZEISS InternationalAlcon Vision LLCOther key market playersAsia Pacific to Exhibit Rapid Growth Fueled by Rising Disposable IncomeThe contact lenses market can be geographically grouped into the Middle East & Africa, North America, Asia Pacific, Latin America, and Europe.
Out of them, North America is set to dominate the market during the forecast period.
It was valued at USD 2.75 billion in 2018.
The global “Nicotine Replacement Therapy Market” is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027.
Additionally, introduction of innovative products by major companies will favor market growth.
This information is published by Fortune Business Insights, in its latest report, titled, “Nicotine Replacement Therapy (NRT) Market Size, Share Impact Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.”The report further observes that the market was valued at USD 2.55 billion in 2019 and is projected to reach USD 3.54 billion by 2027.Major Nicotine Replacement Therapy Market Key players covered in the report include:GlaxoSmithKline plc (U.K, Europe)Johnson & Johnson Inc (New Jersey, U.S)Perrigo Company plc (Ireland, Europe)Pierre Fabre SA, Laboratories (France, Europe)Pfizer Inc. (New York, United States)Cipla Limited (Mumbai, India)British American Tobacco Plc (U.K, Europe)Other PlayersGet Sample Report Of Nicotine Replacement Therapy Market Report at:https://www.fortunebusinessinsights.com/enquiry/sample/nicotine-replacement-therapy-nrt-market-103362Our research methodology is robust and includes data triangulation based on bottom-up and top-down approaches.
We validated the approximate market number with the help of primary research.
Secondary research was conducted to find out detailed information about mergers and acquisitions, collaborations, joint ventures, and agreements.
At the same time, we have derived significant information about the market dynamics associated with growth drivers, trends, and obstacles.It offers figurative estimations for upcoming years on the basis of the recent developments and historic data.
